Treatment of patients with cardiac surgery associated-acute kidney injury

International Journal of Artificial Organs

Volumn 31, Issue 2, 2008, Pages 190-196

  Tolwani, Ashita J ^a   Paganini, E ^b   Joannidis, M ^c   Zamperetti, N ^d   Verbine, A ^d   Vidyasagar, V ^a   Clark, W ^e,f   Ronco, C ^d  

^a University of Alabama at Birmingham   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^d SAN BORTOLO HOSPITAL   (Italy)

^e Medical Strategy and Therapy Development   (United States)

^f INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acute kidney injury; Acute renal failure; Cardiac surgery

Indexed keywords

HEART;

ACUTE KIDNEY INJURY; ACUTE RENAL FAILURE; CARDIAC-SURGERY; DRAFT CONSENSUS; QUALITY INITIATIVES; RENAL FAILURE; RESEARCH STUDIES;

CARDIOVASCULAR SURGERY;

ACETYLCYSTEINE; CLONIDINE; DEXAMETHASONE; DILTIAZEM; DIURETIC AGENT; DOPAMINE; ERYTHROPOIETIN; FENOLDOPAM; FUROSEMIDE; GROWTH FACTOR; HYPERTENSIVE FACTOR; INOTROPIC AGENT; LOOP DIURETIC AGENT; MANNITOL; NESIRITIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PENTOXIFYLLINE; PLACEBO; RECOMBINANT ATRIAL NATRIURETIC FACTOR; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; VASOACTIVE AGENT;

CLINICAL PRACTICE; CLINICAL TRIAL; CONSENSUS DEVELOPMENT; DRUG EFFICACY; DRUG WITHDRAWAL; EVIDENCE BASED MEDICINE; FLUID THERAPY; HEART DISEASE; HEART SURGERY; HIGH RISK PATIENT; HUMAN; KIDNEY INJURY; KIDNEY PERFUSION; LOW DRUG DOSE; PATIENT CARE; REVIEW; RISK ASSESSMENT;

EID: 41149132175     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139880803100212     Document Type: Review

References (75)

1. Stafford-Smith M. Evidence-based renal protection in cardiac surgery. Semin Cardiothorac Vasc Anesth 2005; 9: 65-76.
2. Rosner M, Okusa M. Acute kidney injury associated with cardiac surgery. Clin J Am Soc Nephrol 2006; 1: 19-32.
3. Ihle B. Acute renal dysfunction after cardiac surgery: Still a big problem! Heart, Lung, and Circulation 2007; 16 (Suppl 3): S39-44.
4. Boldt J, Brenner T, Lehmann A, Lang J, Kumle B, Werling C. Influence of two different volume replacement regimens on renal function in elderly patients undergoing cardiac surgery: Comparison of a new starch preparation with gelatin. Intensive Care Med 2003; 29: 763-9.
5. Winkelmayer W, Glynn R, Levin R, Avorn J. Hydroxyethyll starch and change in renal function in patients undergoing coronary artery bypass graft surgery. Kidney Int 2003; 64: 1046-9.
6. Finfer S, Bellomo R, Boyce N, French J, Myburgh J, Norton R. SAFE Study Investigators. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 2004; 350: 2247-56.
7. Boldt J, Brosch C, Ducke M, Papsdorf M. Influence of volume therapy with a modern hydroxyethylstarch preparation on kidney function in cardiac surgery patients with compromised renal function: A comparison with human albumin. Crit Care Med 2007; 35: 2740-6.
8. Roberts I, Alderson P, Bunn F, Chinnock, P, Ker K, Schierhout G. Colloids versus crystalloids for fluid resuscitation in critically ill patients Cochrane Database of Systematic Reviews 2007 Issue 2.
9. Morimatsu H, Uchino S, Chung J, Bellomo R, Raman J, Buxton B. Norepinephrine for hypotensive vasodilatation after cardiac surgery: impact on renal function. Intensive Care Med 2003; 29: 1106-12.
10. Lee R, Giantomasso, D, Bellomo R. Vasoactive drugs and the kidney. Best Pract Res Clin Anaesthesiol 2004; 18: 53-74.
11. Gillies M, Bellomo R, Doolan L, Buxton B. Bench-to-bedside review: inotropic drug therapy after adult cardiac surgery-a systematic literature review. Crit Care 2005; 9: 266-79.
12. Costa P, Ottino GM, Matani A, et al. Low-dose dopamine during cardiopulmonary bypass in patients with renal dysfunction. J Cardiothorac Anesth 1990; 4: 469-73.
13. Denton MD, Chertow GM, Brady HR. Renal dose dopamine for the treatment of acute renal failure: Scientific rationale, experimental studies, and clinical trials. Kidney Int 1996; 49: 4-14.
14. Dogrell SA. The therapeutic potential of dopamine modulators on the cardiovascular and renal systems. Expert Opin Investig Drugs 2002; 11: 631-44.
15. Bellomo R, Chapman M, Finfer S, Hickling K, Myburgh J. Low dose-dopamine in patients with early renal dysfunction: A placebo-controlled randomised trial. Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group. Lancet 2000; 356: 2139-43.
16. Kellum J, Decker J. Use of dopamine in acute renal failure: A meta-analysis. Crit Care Med 2001; 29: 1526-31.
17. Lauschke A, Teichgraber UKM, Frei U, Eckardt K-U. Low-dose dopamine worsens renal perfusion in patients with acute renal failure, Kidney Int 2006; 69: 1669-74.
18. Friedrich JO, Adhikari N, Herridge MS, Beyenne J. Metaanalysis: Low-dose dopamine increases urine output but does not prevent renal dysfunction or death. Ann Intern Med 2005; 142: 510-24.
19. Halpenny M, Lakshmi S, O'Donnell A, O'Callaghan-Enright S, Shorten GD. Fenoldopam: Renal and splanchnic effects in patients undergoing coronary artery bypass grafting. Anaesthesia 2001; 56: 953-60.
20. Shorten G. Fenoldopam: Potential clinical applications in heart surgery. Rev Esp Anestesiol Reanim 2001; 48: 487-91.
21. Garwood D, Swamidoss CP, Davis EA, Samson L, Hines RL. A case series of low-dose fenoldopam in seventy cardiac surgery patients at increased risk of renal dysfunction. J Cardiothorac Vasc Anesth 2003; 17: 17-21.
22. Caimmi PP, Pagani L, Micalizzi E, Fiume G, Guani S, Bernardi M. Fenoldopam for renal protection in patients undergoing cardiopulmonary bypass. J Cardiothorac Vasc Anesth 2003; 17: 491-4.
23. Tumlin JA, Finkel KW, Murray PT, Samuels J, Cotsonis G, Shaw AD. Fenoldopam mesylate in early acute tubular necrosis: a randomized, double-blind, placebo-controlled clinical trial. Am J Kidney Dis 2005; 46: 26-34.
24. Ranucci M, Soro G, Barzaghi N, Locatelli A, Giordano G, Vavassori A, Manzato A, Melchiorri C, Bove T, Juliano G, Uslenghi MF. Fenoldopam prophylaxis of postoperative acute renal failure in high-risk cardiac surgery patients. Ann Thorac Surg 2004; 78: 1332-7.
25. Bove T, Landoni G, Calabro M, Aletti G, Marino G, Cerchierini E, Crescenzi G, Zangrillo A. Renoprotective action of fenoldopam in high-risk patients undergoing cardiac surgery: a prospective, double-blind randomized clinical trial. Circulation 2005; 3230-5.
26. Rahman SN, Kim GE, Mathew AS, Goldberg CA, Allgren R, Schrier RW, Conger JD. Effects of atrial natriuretic peptide in clinical acute renal failure. Kidney Int 1994; 45: 1731-8.
27. Valsson F, Ricksten SE, Hedner T. Lundin S. Effects of atrial natriuretic peptide an acute renal impairment in patients with heart failure after cardiac surgery. Intensive Care Med 1996; 22: 230-6.
28. Sezai A, Shioni M, Orine Y, et al. Low-dose continuous infusion of human atrial natriuretic peptide during and after cardiac surgery. Ann Thorac Surg 2000; 69: 732-8.
29. Sezai A, Hata M, Wakui, S, et al. Efficacy of low-dose continuous infusion of human atrial natriuretic; peptide (hANP) during cardiac surgery. Possibility of postoperative left ventricular remodeling effect. Circ J 2006; 70: 1426-31.
30. Sezai A, Hata M, Wakui S, et al. Efficacy of continuous low-dose hANP administration in patients undergoing emergent coronary artery bypass grafting for acute coronary syndrome. Circ J 2007; 71; 1401-7.
31. Allgren RL, Marbury TC, Rahman SN, Weisberg LS, Fenves AZ, Lafayette RA, Sweet RM, Genter FC, Kurnik BR, Conger JD, Sayegh MH. Anaritide in acute tubular necrosis: Auriculin Anaritide Acute Renal Failure Study Group. N Engl J Med 1997; 336: 828-34.
32. Lewis J, Salem MM, Chertow GM, Weisberg LS, McGrew F, Marbury TC, Allgren RL. Anaritide Acute Renal Failure Study Group. Am J Kidney Dis 2000; 36: 767-74.
33. Sward K, Valsson F, Odencrants P, Samuelsson O, Ricksten SE. Recombinant human atrial natriuretic peptide in ischemic acute renal failure. A randomized placebo controlled trial. Crit Care Med 2004; 32: 1310-15.
34. Salzberg SP, Filsoufi F Anyanwu A, et al. High-risk mitral valve surgery: perioperative hemodynamic optimization with nesiritide (BNP). Ann Thorac Surg 2005; 80: 502-6.
35. Beaver TM, Winterstein AG, Shuster JJ, et al. Effectiveness of nesiritide on dialysis or all-cause mortality in patients undergoing cardiothoracic surgery. Clin Cardiol 2006; 29: 18-24.
36. Mentzer RM, Oz Me Sladen RN, et al. Effects of perioperative nesiritide in patients with left ventricular dysfunction undergoing cardiac surgery. The NAPA Trial. J Am Coll Cardiol 2007; 49: 716-26.
37. Lombardi R, Ferriero A, Servetto C. Renal function afater cardiac surgery: adverse effect of furosemide. Ren Fail 2003; 25: 775-86.
38. Sirivella A, Gielchinsky I, Parsonnet V. Mannitol, furosemide, and dopamine infusion in postoperative renal failure complicating cardiac surgery. Ann Thorac Surg 2000; 69: 501-6.
39. Kleinknecht D, Ganeval D, Gonzales-Duque LA, Fermanian J. Furosemide in acute oliguric renal failure. A controlled trial. Nephron 1976; 17: 51-8.
40. Nuutinen L, Hollmen A. The effect of prophylactic use of furosemide on renal function during open heart surgery. Ann Chir Gynaecol 1967; 65: 258-66.
41. Brown CB, Ogg CS, Cameron JS. High dose furosemide in acute renal failure: a controlled trial. Clin Nephrol 1981; 15: 90-6.
42. Shilliday I, Quinn K, Allison, M. Loop diuretics in the management of acute renal failure: a prospective, double-blind, placebo-controlled, randomized study. Nephrol Dial Transplant 1997; 12: 2593-6.
43. Kellum, JA. The use of diuretics and dopamine in acute renal failure: a systematic review of the evidence. Crit Care 1997; 1: 53-9.
44. Lassnigg A, Donner E, Grubhofer G, Presterl E, Druml W, Hiesmayr. Lack of renoprotective effects of dopamine and furosemide during cardiac surgery. J Am Soc Nephrol 2000; 11: 97-104.
45. Venkataram R, Kellum JA. The role of diuretic agents in the management of acute renal failure. Contrib Nephrol 2001; 158-70.
46. Mehta, RL, Pascual MT, Soroko S, Chertow GM for the PICARD Study Group. Diuretics, mortality, and nonrecovery of renal function in acute renal failure. JAMA 2002; 288: 2547-53.
47. Carcoana OV, Mathew JP. Davis E, Byrne DW, Hayslett JP, Hines RL, Garwood S. Mannitol and dopamine in patients undergoing cardiopulmonary bypass: A randomized clinical trial. Anesth Analg 2003; 97: 1222-9.
48. Uchino S, Doig GS, Bellomo R, Morimatsu H, Morgera S, Schetz M, Tan I, Bouman, C, Nacedo E, Gibney N, Tolwani A, Ronco C, Kellum JA; Beginning and Ending Supportive Therapy for the Kidney (B.E.S.T Kidney Investigators). Crit Care Med 2004; 32: 1669-77.
49. Ho KM, Sheridan DJ. Meta-analysis of furosemide to prevent or treat acute renal failure. BMJ 2006; 333; 406-7.
50. Bagshaw SM, Delaney A, Haase M, Ghali WA, Bellorno R. Loop diuretics in the management of acute renal failure: A systematic review and meta-analysis. Crit Care Resusc 2007; 9: 60-8.
51. Cote G, Denault A, Belisle S, et al. N-acetylcysteine in the preservation of renal function in patients undergoing cardiac surgery. ASA Annual Meeting Abstracts 2003; Abstract 420.
52. Haase, M, Haase-Fielitz A, Bagshaw S, Reade M, Morgera S, Seevenayagam S, Matalanis G, Buxton B, Doolan L, Bellomo R. Phase II, randomized, controlled trial of high-dose N-acetylcyteine in high-risk cardiac surgery patients. Crit Care Med 2007; 35: 1324-31.
53. Boldt J, Brosch C, Piper SN, Suttner S, Lehmann A, Werling C. Influence of prophylactic use of pentoxifylline on post-operative renal function impairment during cardiac surgery with cardiopulmonary bypass. Crit Car Med 2001; 29: 952-8.
54. Loef BG, Henning RH, Epema AH, Rietman GW, van Oeveran W, Navis GJ, Ebels T. Effect of dexamethasone on penoperative renal function impairment during cardiac surgery with cardiopulmonary bypass. Br J Anaesth 2004; 93: 793-8.
55. Myles PS, Hunt JO, Holdgaard HO, McRae R, Buckland MR, Moloney J, Hall J, Bujor MA, Esmore DS, Davis BB, Morgan DJ. Clonidine and cardiac surgery: Haemodynamic and metablic effects, myocardial ischaemia and recovery. Anaesth Intensive Care 1999; 27: 137-47.
56. Bergman AS, Odar-Cederlof I, Westman L, Bjellerup P, Hoglund P, Ohqvist G. Diltiazem infusion for renal protection in cardiac surgical patients with preexisting renal dysfunction. J Cadiothorac Vase Anesth 2002; 16: 294-9.
57. Piper SN, Kumle B, Maleck WH, Kiessling AH, Lehmann A, Rohm KD, Suttner SW, Boldt J. Diltiazem may preserve renal tubular integrity after cardiac surgery. Can J Anaesth 2003; 50: 285-92.
58. Young EW, Diab A, Kirsh MM. Intravenous diltiazem and acute renal failure after cardiac operations. Ann Thorac Surg 1998; 65: 1316-19.
59. Hirschberg R, Kopple J, Lipsett P, Benjamin E, Minei J, Albertson T, Munger M, Metzler M, Zaloga G, Murray M, Lowry S, Conger J, McKeown W, O'Shea M, Warnock D, Summer W, Hintz R, Meyers B Haenftling K, Capra W, et al. Multicenter clinical trial of recombinant human insulin-like growth factor I in patients with acute renal failure. Kidney Int 1999; 55: 2423-32.
60. Vesey DA, Cheung C, Pat B, Endre Z, Gobe G, Johnson DW. Erythropoietin protects against ischaemic acute renal injury. Nephrol Dial Transplant 2004; 19: 348-55.
61. Sharples EJ, Patel N, Brown P, Stewart K, Mota-Philipe H, Sheaff M, Kieswich J, Allen D, Harwood S, Raftery M, Thiemermann C, Yaqoob MM. Erythropoietin protects the kidney against the injury and dysfunction caused by ischemia-reperfusion. J Am Soc Nephrol 2004; 15: 2115-24.
62. Paret G, Cohen AJ, Bohn DJ, et al. Continuous arteriovenous hemofiltration after cardiac operations in infants and children. J Thorac Cardiovasc Surg 1992; 104: 1225-30.
63. Bastien O, Saroul C, Hercule C, George M, Estanove S. Continuous venovenous hemodialysis after cardiac surgery. Contrib Nephrol 1991; 93: 76-8.
64. Bent P, Tan HK, Bellomo R, Buckmaster J, Doolan L, Hart G, Silvester W, Gutteridge G, Matalanis G, Raman J, Rosalion A, Buxton BF. Early and intensive continuous hemofiltration for severe renal failure after cardiac surgery. Ann Thorac Surg 2001; 71: 832-7.
65. Durmaz I, Yadgi T, Calkavur T, Mahmudov R, Apaydin AZ, Posacioglu H, Atay Y, Engin C. Prophylactic dialysis in patients with renal dysfunction undergoing on-pump coronary artery bypass surgery. Ann Thorac Surg 2003; 75: 859-64.
66. Lugones F, Chiotti G, Carrier M, Parent D, Thibodeau J, Ducharme B, Cardinal J, Leblanc Martine. Continuous renal replacement therapy after cardiac surgery. Blood Purif 2004; 22: 249-55.
67. Elahi MM, Lin MY, Joseph RN, Dhannapuni RR Spyt TJ. Early hemofiltration improves survival in post-cardiotomy patients with acute renal failure. Eur J Cardiothorac Surg 2004; 26: 1027-31.
68. Bapat V, Sabetai, Roxburgh J, Young C, Venn G. Early and intensive continuous venovenous hemofiltration for acute renal failure after cardiac surgery. Interact Cardiovasc Thorac Surg 2004; 3: 426-30.
69. Demirkilic U, Kuralay E, Yenicesu M, Caglar K, Oz B, Cingoz F, Gunay C, Yildirim V, Celyan S, Arslan M, Vural, A, Tatar H. Timing of replacement therapy for acute renal failure after cardiac surgery. J Card Surg 2004; 19: 17-20.
70. Ehrlich M, Garlicki M, Swistowski J, Labus K, Gotebiewski S, Rydezewski, A. Results after haemofiltration for acute renal failure after cardiac surgery. Kariochirurgia Torakochirugria Polska 2006; 3: 323-5.
71. Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, Levin A; the Acute Kidney Injury Network. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007 Mar 1; 11: R31.
72. Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in the critically ill patients. N Engl J Med 2001; 345: 1359-67.
73. Rondon-Berrios H, Palevsky P. Treatment of acute kidney injury: an update on the management of renal replacement therapy. Curr Opin Nephrol Hypertens 2007; 16: 6470.
74. Palevsky P. Clinical review: Timing and dose of continuous renal replacement therapy in acute kidney injury. Crit Care 2007; 11: 232.
75. D'Intini V, Ronco C, Bonello M, Bellomo R. Renal replacement therapy in acute renal failure. Best Pract Res Clin Anaesthesiol 2004; 18: 145-57.